1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global HIV Diagnosis Market, By Product
5.1 Introduction
5.2 Software & Services
5.3 Instruments
5.4 Consumables
5.4.1 Assays and Kits & Reagents
5.4.2 Other Consumables
6 Global HIV Diagnosis Market, By Test Type
6.1 Introduction
6.2 Antibody Tests
6.2.1 HIV-1 Screening Tests
6.2.1.1 Elisa
6.2.1.2 Home Access Dried Blood Spots
6.2.1.3 Rapid Tests
6.2.2 HIV-1 Antibody Confirmatory Tests
6.2.2.1 Western Blot Tests
6.2.2.2 Line Immunoassays
6.2.2.3 Indirect Immunofluorescence Assays (IFA)
6.2.2.4 Radio-Immunoprecipitation Assays
6.2.3 HIV-2 & Group O Diagnostic Tests
6.3 Viral Load Tests
6.4 Tests for Early Infant Diagnosis
6.5 CD4 Tests
6.6 Tests for Viral Identification
7 Global HIV Diagnosis Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
7.3 Diagnostic Laboratories
7.4 Home Settings
7.5 Other End Users
8 Global HIV Diagnosis Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott Laboratories
10.2 Roche Diagnostics
10.3 Merck KGaA
10.4 Siemens Healthineers
10.5 Thermo-Fisher Scientific Inc.
10.6 Beckman Coulter, Inc.
10.7 Hologic Inc.
10.8 Becton, Dickinson & Company
10.9 Bio-Rad Laboratories
10.10 Alere Inc.
10.11 OraSure Technologies, Inc.
10.12 Zyomyx Incorporation
10.13 Chembio Diagnostic Systems, Inc.
10.14 Janssen Pharmaceutica NV
10.15 Bristol –Myers Squibb
List of Tables
Table 1 Global HIV Diagnosis Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 4 Global HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 5 Global HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 6 Global HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 7 Global HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 8 Global HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 9 Global HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 10 Global HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 11 Global HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 12 Global HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 13 Global HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 14 Global HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 15 Global HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 16 Global HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 17 Global HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 18 Global HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 19 Global HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 20 Global HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 21 Global HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 22 North America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 23 North America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 24 North America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 25 North America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 26 North America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 27 North America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 28 North America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 29 North America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 30 North America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 31 North America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 32 North America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 33 North America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 34 North America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 35 North America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 36 North America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 37 North America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 38 North America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 39 North America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 40 North America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 41 North America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 42 North America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 43 Europe HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 44 Europe HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 45 Europe HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 46 Europe HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 47 Europe HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 48 Europe HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 49 Europe HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 50 Europe HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 51 Europe HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 52 Europe HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 53 Europe HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 54 Europe HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 55 Europe HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 56 Europe HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 57 Europe HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 58 Europe HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 59 Europe HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 60 Europe HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 61 Europe HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 62 Europe HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 63 Europe HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 64 Asia Pacific HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 65 Asia Pacific HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 66 Asia Pacific HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 67 Asia Pacific HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 68 Asia Pacific HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 69 Asia Pacific HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 70 Asia Pacific HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 71 Asia Pacific HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 72 Asia Pacific HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 73 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 74 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 75 Asia Pacific HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 76 Asia Pacific HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 77 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 78 Asia Pacific HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 79 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 80 Asia Pacific HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 81 Asia Pacific HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 82 Asia Pacific HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 83 Asia Pacific HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 84 Asia Pacific HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 85 South America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 86 South America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 87 South America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 88 South America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 89 South America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 90 South America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 91 South America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 92 South America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 93 South America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 94 South America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 95 South America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 96 South America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 97 South America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 98 South America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 99 South America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 100 South America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 101 South America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 102 South America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 103 South America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 104 South America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 105 South America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 106 Middle East & Africa HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 107 Middle East & Africa HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 108 Middle East & Africa HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 109 Middle East & Africa HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 110 Middle East & Africa HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 111 Middle East & Africa HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 112 Middle East & Africa HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 113 Middle East & Africa HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 114 Middle East & Africa HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 115 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 116 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 117 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 118 Middle East & Africa HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 119 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 120 Middle East & Africa HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 121 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 122 Middle East & Africa HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 123 Middle East & Africa HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 124 Middle East & Africa HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 125 Middle East & Africa HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 126 Middle East & Africa HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 HIV診断は、ヒト免疫不全ウイルス（HIV）に感染しているかどうかを判断するための医療的なプロセスです。HIVは、白血球を攻撃し、体の免疫系を弱体化させるウイルスで、未治療のまま放置するとエイズ（後天性免疫不全症候群）を引き起こす可能性があります。そのため、HIVの早期発見と診断は、感染者が適切な治療を受け、ウイルスの拡散を防ぐために非常に重要です。 HIV診断には主にいくつかの種類があります。最も一般的なのは、抗体検査です。この検査は、体がHIVに感染したときにproducedされる抗体を検出します。抗体検査は通常、血液や唾液のサンプルを用いて行われ、結果が出るまでに数時間から数日かかることがあります。最近では、迅速検査も普及しており、検体を採取してから数十分で結果が出る場合もあります。 もう一つの方法は、抗原検査です。HIVウイルスの一部である抗原を検出し、抗体検査に比べて感染早期の診断が可能です。これにより、感染後数週間での診断ができるため、感染の早期発見に寄与します。抗原検査も血液サンプルを用いて行われます。 さらに、核酸検査（NAAT）という方法もあります。これは、ウイルスの遺伝子そのものを検出するもので、非常に高い精度で感染を確認できますが、一般的には費用が高く、通常のスクリーニングには用いられません。主に、高リスクの集団や、他の検査で陰性結果が出た背景に疑いのあるケースで用いられます。 HIV診断は、感染症の管理や治療において多くの用途があります。まず、感染者が早期に治療を受けることで、HIVがエイズに進行するのを防ぎ、より良い健康状態を維持できるようになります。また、HIVポジティブ者が適切な治療を受けながらウイルス量を抑えることで、性的接触や血液を介して他者にウイルスを感染させるリスクを大幅に減少させることができます。これは、治療として望ましい状態である「ウイルス抑制」によって実現します。 HIV診断を受けることは、診断結果に対する精神的な影響や、社会的なスティグマが伴う場合もあり、カウンセリングや心理的サポートが重要になります。診断を受けた際には、適切な医療機関やサポートグループと連携することが望ましいです。 関連技術としては、診断に用いられる機器や試薬があり、これらの進化により診断精度や迅速性が向上しています。例えば、スマートフォンで使用できる簡易検査キットが登場し、自宅での検査が可能になってきています。このような技術の発展により、HIV診断へのアクセスも一層向上しています。また、遺伝子解析技術やデジタルヘルスの進展によって、より個別化された治療やフォローアップが現実のものとなっています。 さらに、HIV診断は疫学的監視にも用いられ、国や地域におけるHIVの流行状況を把握するために重要なデータを提供します。これに基づき、公共の健康政策やリソース配分が行われ、効果的な予防活動や治療計画が策定されます。こうした全体の流れは、HIV感染拡大の防止に向けた努力に大きく寄与しています。 これらの情報からも明らかなように、HIV診断は単なる医療行為ではなく、個人の健康管理や社会全体の健康増進において非常に重要な役割を果たしています。早期発見や早期治療の重要性を理解し、定期的な検査を受けることが推奨されます。HIVに対する理解や認識を高めることで、多くの人々が健康で生きるための道を切り開いていくことができます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
